JPWO2020223541A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020223541A5 JPWO2020223541A5 JP2021564454A JP2021564454A JPWO2020223541A5 JP WO2020223541 A5 JPWO2020223541 A5 JP WO2020223541A5 JP 2021564454 A JP2021564454 A JP 2021564454A JP 2021564454 A JP2021564454 A JP 2021564454A JP WO2020223541 A5 JPWO2020223541 A5 JP WO2020223541A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- combination
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025080870A JP2025122028A (ja) | 2019-05-01 | 2025-05-14 | Ｉｌ－３３アンタゴニストを投与することにより喘息を治療するまたは予防するための方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962841481P | 2019-05-01 | 2019-05-01 | |
| US62/841,481 | 2019-05-01 | ||
| US201962848248P | 2019-05-15 | 2019-05-15 | |
| US62/848,248 | 2019-05-15 | ||
| US201962898900P | 2019-09-11 | 2019-09-11 | |
| US62/898,900 | 2019-09-11 | ||
| PCT/US2020/030824 WO2020223541A1 (en) | 2019-05-01 | 2020-04-30 | Methods for treating or preventing asthma by administering an il-33 antagonist |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025080870A Division JP2025122028A (ja) | 2019-05-01 | 2025-05-14 | Ｉｌ－３３アンタゴニストを投与することにより喘息を治療するまたは予防するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022530533A JP2022530533A (ja) | 2022-06-29 |
| JPWO2020223541A5 true JPWO2020223541A5 (https=) | 2024-09-13 |
| JP2022530533A5 JP2022530533A5 (https=) | 2024-09-13 |
Family
ID=70802932
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564454A Pending JP2022530533A (ja) | 2019-05-01 | 2020-04-30 | Ｉｌ－３３アンタゴニストを投与することにより喘息を治療するまたは予防するための方法 |
| JP2025080870A Pending JP2025122028A (ja) | 2019-05-01 | 2025-05-14 | Ｉｌ－３３アンタゴニストを投与することにより喘息を治療するまたは予防するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025080870A Pending JP2025122028A (ja) | 2019-05-01 | 2025-05-14 | Ｉｌ－３３アンタゴニストを投与することにより喘息を治療するまたは予防するための方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210000949A1 (https=) |
| EP (1) | EP3962515A1 (https=) |
| JP (2) | JP2022530533A (https=) |
| KR (1) | KR20220004708A (https=) |
| CN (1) | CN113766931A (https=) |
| AU (1) | AU2020266593B2 (https=) |
| BR (1) | BR112021021195A2 (https=) |
| CA (1) | CA3138306A1 (https=) |
| CO (1) | CO2021015793A2 (https=) |
| IL (1) | IL287275A (https=) |
| MA (1) | MA55807A (https=) |
| MX (1) | MX2021013427A (https=) |
| SG (1) | SG11202111255YA (https=) |
| TW (1) | TWI894144B (https=) |
| WO (1) | WO2020223541A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6306588B2 (ja) | 2012-08-21 | 2018-04-04 | サノフィ・バイオテクノロジー | Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法 |
| ES2994774T3 (en) | 2016-09-01 | 2025-01-31 | Regeneron Pharma | Methods for preventing or treating allergy by administering an il-4r antagonist |
| CN113597328B (zh) | 2019-03-21 | 2025-10-31 | 瑞泽恩制药公司 | 用于治疗过敏症的il-4/il-13途径抑制剂和浆细胞消融的组合 |
| WO2021011614A1 (en) | 2019-07-16 | 2021-01-21 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an il-4r antagonist |
| AU2022335719B2 (en) | 2021-08-27 | 2024-11-28 | Medimmune Limited | Treatment of chronic obstructive pulmonary disease with an anti-interleukin-33 antibody |
| MX2024005769A (es) * | 2021-11-11 | 2024-05-24 | Regeneron Pharma | Tratamiento de la enfermedad pulmonar basado en la estratificacion de puntuacion de riesgo poligenico para la interleucina 33 (il-33). |
| TW202423972A (zh) | 2022-08-26 | 2024-06-16 | 英商梅迪繆思有限公司 | 使用抗介白素－３３抗體的氣喘治療 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6927044B2 (en) | 1998-09-25 | 2005-08-09 | Regeneron Pharmaceuticals, Inc. | IL-1 receptor based cytokine traps |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US8178098B2 (en) | 2001-04-03 | 2012-05-15 | National Jewish Health | Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies |
| ES2398076T3 (es) | 2006-06-02 | 2013-03-13 | Regeneron Pharmaceuticals, Inc. | Anticuerpos de alta afinidad contra el receptor de IL-6 humano |
| BR112013008366B1 (pt) | 2010-10-06 | 2022-02-08 | Regeneron Pharmaceuticals, Inc | Formulações farmacêuticas líquidas estáveis contendo anticorpos anti-receptor de interleucina-4 humana alfa, e recipiente contendo as referidas formulações |
| JP6306588B2 (ja) * | 2012-08-21 | 2018-04-04 | サノフィ・バイオテクノロジー | Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法 |
| JO3532B1 (ar) * | 2013-03-13 | 2020-07-05 | Regeneron Pharma | الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها |
| IL315136A (en) * | 2014-02-21 | 2024-10-01 | Sanofi Biotechnology | Methods for treating or preventing asthma by administering an il-4rantagonist |
| TWI857389B (zh) * | 2016-12-01 | 2024-10-01 | 美商再生元醫藥公司 | 治療發炎症狀的方法 |
| ES3052989T3 (en) * | 2017-04-13 | 2026-01-16 | Regeneron Pharma | Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding il33 and il1rl1 |
| SG11201909048TA (en) * | 2017-04-21 | 2019-11-28 | Genentech Inc | Use of klk5 antagonists for treatment of a disease |
-
2020
- 2020-04-30 SG SG11202111255YA patent/SG11202111255YA/en unknown
- 2020-04-30 CN CN202080032942.1A patent/CN113766931A/zh active Pending
- 2020-04-30 EP EP20727763.3A patent/EP3962515A1/en active Pending
- 2020-04-30 KR KR1020217038970A patent/KR20220004708A/ko active Pending
- 2020-04-30 US US16/863,800 patent/US20210000949A1/en active Pending
- 2020-04-30 MA MA055807A patent/MA55807A/fr unknown
- 2020-04-30 MX MX2021013427A patent/MX2021013427A/es unknown
- 2020-04-30 TW TW109114586A patent/TWI894144B/zh active
- 2020-04-30 WO PCT/US2020/030824 patent/WO2020223541A1/en not_active Ceased
- 2020-04-30 AU AU2020266593A patent/AU2020266593B2/en active Active
- 2020-04-30 CA CA3138306A patent/CA3138306A1/en active Pending
- 2020-04-30 JP JP2021564454A patent/JP2022530533A/ja active Pending
- 2020-04-30 BR BR112021021195A patent/BR112021021195A2/pt unknown
-
2021
- 2021-10-14 IL IL287275A patent/IL287275A/en unknown
- 2021-11-24 CO CONC2021/0015793A patent/CO2021015793A2/es unknown
-
2025
- 2025-05-14 JP JP2025080870A patent/JP2025122028A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025038127A5 (https=) | ||
| JP2025072593A5 (https=) | ||
| JP2023052457A5 (https=) | ||
| EP3703818B1 (en) | Il-4r antagonist for use in a method for treating or preventing asthma | |
| JP2023162343A5 (https=) | ||
| CN111437387B (zh) | 通过施用il-4r拮抗剂治疗鼻息肉症的方法 | |
| EP3973987B1 (en) | Combination comprising an il-4r antagonist, a corticosteroid and a long-acting beta2-adrenergic agonist for treating asthma | |
| CN104755495A (zh) | 通过施用il-4r拮抗剂治疗或预防哮喘的方法 | |
| JP2024129140A5 (https=) | ||
| JP2015527364A5 (https=) | ||
| TWI894144B (zh) | 藉由投予il-33拮抗劑治療或預防哮喘之方法 | |
| CN112153982A (zh) | 用于通过施用il-4r抑制剂治疗特应性皮炎的方法 | |
| KR102337599B1 (ko) | 벤랄리주맙을 이용하여 천식 환자에서 강제 호기량을 증가시키는 방법 | |
| KR102337601B1 (ko) | 벤랄리주맙을 이용하여 천식 증상을 개선시키는 방법 | |
| US20240360232A1 (en) | Methods for treating chronic obstructive pulmonary disease (copd) by administering an il-4r antagonist | |
| JPWO2020223541A5 (https=) | ||
| RU2021134810A (ru) | Способы лечения или предупреждения астмы посредством введения антагониста il-33 | |
| JP2020105193A5 (https=) | ||
| JPWO2021113707A5 (https=) | ||
| RU2023120407A (ru) | Способы лечения или предотвращения астмы посредством введения антагониста il-4r | |
| HK40107894A (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
| Chen et al. | Capsular Thyroid Injection Therapy Under Ultrasound Guidance for the Treatment of Subacute Thyroiditis | |
| HK40036672B (en) | Il-4r antagonist for use in a method for treating or preventing asthma | |
| HK40036672A (en) | Il-4r antagonist for use in a method for treating or preventing asthma | |
| WO2025221640A1 (en) | Methods for treating chronic rhinosinusitis without nasal polyps by administering an il-4r antagonist |